just about 19 million shares now. small pipeline with only 1 promising drug and it's only in Phase 2.
mkt cap @ 7.00 = about 130 million.
I don't think TSPT deserves any more than a 80-90 million mkt cap until we see how much they can earn on Mezzo. I also believe the Secondary was a "quick fix" shortsighted move by management, because they acted like babies without considering the reception of the investment community. They could have shewn confidence and waited 3-6 months to actually earn money and use that to develop 2061 instead of wanting money right away and putting it on the backs of innocent shareholders ! The stock is going to 5.00 and we will see if that holds, I think it will only because of Mezzo, but if Mezzo earnings to TSPT dissapoint $3 is not out of the question. Shareholders thought the milestone approval payment would cushion cash, management says no, we need more, this is sad, because they could have sold the entire company but chose to bleed the public instead, this is going lower.